Back in early 2019, news of a major innovation called Micro-Coring created quite the buzz in the aesthetic world for touting skin-tightening and anti-aging benefits rivaling a facelift, but without surgery. However, it was still too new for potential patients to get excited because the company working on the proprietary technology behind the scenes, Cytrellis, had yet to receive its clearance from the FDA (a critical step in order to move forward with the launch of any new aesthetic treatment).

Fast-forward to this week, and the time has finally come: Cytrellis just received the green light for the device, which it’s named the ellacor system with Micro-Coring technology, and will be marketing as a minimally invasive method for reducing moderate-to-severe wrinkles in the mid and lower face.

Read the full article at